Cas:58791-79-0 5-amino-1-(2,4-dichlorophenyl)pyrazole-4-carbonitrile manufacturer & supplier

Chemical Name:5-amino-1-(2,4-dichlorophenyl)pyrazole-4-carbonitrile

CAS.NO:58791-79-0

Synonyms:5-amino-1-(2′,4′-dichlorophenyl)pyrazole-4-carbonitrile;5-amino-4-cyano-1-(2,4-dichlorophenyl)pyrazole;1H-pyrazole-4-carbonitrile,5-amino-1-(2,4-dichlorophenyl);5-amino-1-(2,4-dichloro-phenyl)-1H-pyrazole-4-carbonitrile;5-Amino-4-cyano-1-(2,4-dichlorophenyl)-pyrazol;HMS546G14

Molecular Formula:C₁₀H₆Cl₂N₄

Molecular Weight:253.08700

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:453.8ºC at 760mmHg

Density:1.54g/cm3

Index of Refraction:1.701

PSA:67.63000

Exact Mass:251.99700

LogP:3.21418

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 5-amino-1-(2′,4′-dichlorophenyl)pyrazole-4-carbonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,HMS546G14 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1H-pyrazole-4-carbonitrile,5-amino-1-(2,4-dichlorophenyl) Use and application,HMS546G14 technical grade,usp/ep/jp grade.

Related News: Citizens and residents will be allowed entry to New Zealand, but will be required to quarantine themselves for 14 days, Prime Minister Jacinda Ardern said. 5-amino-1-(2,4-dichlorophenyl)pyrazole-4-carbonitrile manufacturer The FDA issued a stark warning to the public urging them to stop using rapid COVID-19 antigen tests developed by Innova Medical Group, the company previously tapped by the U.K. government for hundreds of millions of kits to help regularly screen the country’s population. 5-amino-1-(2,4-dichlorophenyl)pyrazole-4-carbonitrile supplier China will use its national drug bulk-buy scheme to lower the price of drugs currently sold at higher prices compared with other markets, it said in an official statement. 5-amino-1-(2,4-dichlorophenyl)pyrazole-4-carbonitrile vendor From the perspective of the overall life cycle of generic drugs from R & D to sales, with the expiration of patents, the business model for the production and marketing of generic pharmaceutical raw materials has changed, demand has increased, business potential has been realized quickly, and gross profit margins have shown a downward trend. 5-amino-1-(2,4-dichlorophenyl)pyrazole-4-carbonitrile factory From the perspective of the overall life cycle of generic drugs from R & D to sales, with the expiration of patents, the business model for the production and marketing of generic pharmaceutical raw materials has changed, demand has increased, business potential has been realized quickly, and gross profit margins have shown a downward trend.